|
Volumn 13, Issue 8, 2001, Pages 1589-1599
|
Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease
a a a a |
Author keywords
6 hydroxydopamine; Cell death; Glial cell line derived neurotrophic factor; Parkinson's disease; Paw use; Sensorimotor behaviour; Stepping; Stereology; Tyrosine hydroxylase
|
Indexed keywords
AMPHETAMINE;
APOMORPHINE;
GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;
OXIDOPAMINE;
RECOMBINANT GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CELL LOSS;
CONTROLLED STUDY;
DOSE TIME EFFECT RELATION;
FEMALE;
LOCOMOTION;
MOTOR PERFORMANCE;
NERVE DEGENERATION;
NEUROPROTECTION;
NIGRONEOSTRIATAL SYSTEM;
NONHUMAN;
PARKINSON DISEASE;
PRIORITY JOURNAL;
RAT;
SUBSTANTIA NIGRA;
AMPHETAMINE;
ANIMALS;
CORPUS STRIATUM;
DOPAMINE;
FEMALE;
GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR;
INFUSION PUMPS;
INJECTIONS, INTRAVENTRICULAR;
MOTOR ACTIVITY;
NERVE DEGENERATION;
NERVE GROWTH FACTORS;
NERVE TISSUE PROTEINS;
OXIDOPAMINE;
PARKINSON DISEASE;
PARKINSON DISEASE, SECONDARY;
RATS;
RATS, SPRAGUE-DAWLEY;
ROTATION;
STEREOTYPED BEHAVIOR;
SUBSTANTIA NIGRA;
TIME FACTORS;
TYROSINE 3-MONOOXYGENASE;
|
EID: 0035011904
PISSN: 0953816X
EISSN: None
Source Type: Journal
DOI: 10.1046/j.0953-816X.2001.01534.x Document Type: Article |
Times cited : (117)
|
References (41)
|